China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 17.01
+0.52 (3.15%)
Jun 1, 2026, 3:04 PM CST
SHE:300294 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,577 | 11,396 | 15,269 | 16,983 | 18,435 | 19,338 | |
Market Cap Growth | -36.05% | -25.36% | -10.10% | -7.88% | -4.67% | 35.36% |
Enterprise Value | 5,777 | 8,289 | 10,035 | 11,919 | 13,978 | 17,731 |
Last Close Price | 17.01 | 22.50 | 29.78 | 32.65 | 35.25 | 36.79 |
PE Ratio | 2496.95 | 101.12 | 38.46 | 71.52 | 42.66 | 56.13 |
Forward PE | 25.58 | 19.56 | 26.00 | 29.00 | 30.95 | 32.40 |
PS Ratio | 4.65 | 5.53 | 8.80 | 6.40 | 6.68 | 7.30 |
PB Ratio | 1.15 | 1.53 | 2.04 | 2.32 | 2.53 | 2.79 |
P/TBV Ratio | 1.35 | 1.80 | 2.55 | 2.43 | 2.97 | 3.23 |
P/FCF Ratio | - | - | 149.71 | 30.64 | 40.25 | 15.14 |
P/OCF Ratio | - | 186.32 | 50.93 | 26.47 | 30.91 | 14.37 |
EV/Sales Ratio | 3.13 | 4.03 | 5.78 | 4.49 | 5.07 | 6.69 |
EV/EBITDA Ratio | 18.47 | 19.93 | 19.23 | 19.09 | 23.28 | 34.72 |
EV/EBIT Ratio | 37.52 | 30.37 | 23.77 | 22.52 | 27.56 | 42.78 |
EV/FCF Ratio | -9.21 | - | 98.40 | 21.51 | 30.52 | 13.88 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.24 | 0.16 | 0.02 | 0.04 | 0.06 | 0.07 |
Debt / FCF Ratio | - | - | 0.12 | 0.04 | 0.08 | 0.03 |
Net Debt / Equity Ratio | -0.37 | -0.42 | -0.47 | -0.72 | -0.64 | -0.61 |
Net Debt / EBITDA Ratio | -9.11 | -7.61 | -6.68 | -8.49 | -7.81 | -8.32 |
Net Debt / FCF Ratio | 4.47 | 6.68 | -34.18 | -9.56 | -10.24 | -3.33 |
Asset Turnover | 0.22 | 0.24 | 0.21 | 0.33 | 0.35 | 0.42 |
Inventory Turnover | 0.96 | 1.05 | 0.79 | 2.06 | 1.87 | 1.74 |
Quick Ratio | 4.87 | 4.06 | 5.40 | 12.85 | 7.65 | 7.83 |
Current Ratio | 6.32 | 5.06 | 6.74 | 14.08 | 8.61 | 8.95 |
Return on Equity (ROE) | 0.04% | 1.51% | 5.36% | 3.40% | 6.27% | 6.45% |
Return on Assets (ROA) | 1.14% | 2.00% | 3.25% | 4.17% | 4.05% | 4.05% |
Return on Invested Capital (ROIC) | 3.45% | 6.60% | 11.64% | 16.09% | 16.13% | 10.41% |
Return on Capital Employed (ROCE) | 2.00% | 3.60% | 5.50% | 7.20% | 6.90% | 5.90% |
Earnings Yield | 0.04% | 0.99% | 2.60% | 1.40% | 2.34% | 1.78% |
FCF Yield | -7.31% | -4.16% | 0.67% | 3.26% | 2.48% | 6.60% |
Dividend Yield | 1.35% | 0.99% | 1.07% | 0.92% | 0.57% | 0.41% |
Payout Ratio | 4561.28% | 138.77% | 58.54% | 42.47% | 19.25% | 13.36% |
Buyback Yield / Dilution | -2.65% | -1.94% | 0.54% | -0.53% | -15.24% | -2.30% |
Total Shareholder Return | -1.30% | -0.95% | 1.61% | 0.38% | -14.67% | -1.89% |